146 件中 1 - 20 件目
英語 ：Wada N, Ishikawa M, Nagabuchi M, Makino S, Miyauchi K, Abe N, Kakizaki H. , Deterioration of bladder compliance after botulinum toxin A injection and discontinuation of medication for overactive bladder. , Int J Urology Case Reports, 5 （384 - 388） , 2022
英語 ：Yoshida M, Gotoh M, Yokoyama O, Kakizaki H, Yamanishi T, Yamaguchi O. , Efficacy of TAC-302 for patients with detrusor underactivity and overactive bladder: a randomized, double-blind, placebo-controlled phase 2 study. , World Journal of Urology, 40 (11) （2799 - 2805） , 2022
英語 ：Wada N, Abe N, Miyauchi K, Ishikawa M, Makino S, Kakizaki H. , Dutasteride add-on treatment to tadalafil for patients with benign prostatic enlargement is similarly effective as dutasteride add-on treatment to alpha blocker: a propensity-score matching analysis. , Int Urol Nephrol, 54 (6) （1193 - 1198） , 2022
英語 ：Takeda T, Shonaka T, Tani C, Hayashi T, Kakizaki H, Sumi Y. , Gracilis muscle flap combined with a laparoscopic transabdominal approach is effective in the treatment of post-prostatectomy rectourethral fistula: A case report. , Int J Surgery Case Reports, 92 , 2022
英語 ：Wada N, Abe N, Miyauchi K, Ishikawa M, Kakizaki H. , Risk factors for failure of long-term dutasteride add-on treatment to alpha-adrenergic antagonist for patients with lower urinary tract symptoms and benign prostatic enlargement. , Int Urol Nephrol, 54 (1) （3 - 36） , 2022
英語 ：Wada N, Watanabe M, Ishikawa M, Takeuchi K, Miyauchi K, Abe N, Banjo H, Kita M, Kakizaki H. , Uroflowmetry pattern in detrusor underactivity and bladder outlet obstruction in male patients with lower urinary tract symptoms. , Lower Urinary Tract Symptoms , 2021
英語 ：Yoshida M, Takeda M, Gotoh M, Yokoyama O, Kakizaki H, Takahashi S, Masumori N, Nagai S, Minemura K. , Cardiovascular safety of vibegron, a new β3-adrenoceptor agonist, in older patients with overactive bladder: Post-hoc analysis of a randomized, placebo-controlled, double-blind comparative phase 3 study. , Neurourology and Urodynamics, 40 (6) （1651 - 1660） , 2021
英語 ：Katoh T, Kakizaki H, Lee KS, et al , Cardiovascular safety of mirabegron add-on therapy to tamsulosin for the treatment of overactive bladder in men with lower urinary tract symptoms: A post-hoc analysis from the MATCH study. , Lower Urinary Tract Symptoms, 13 (1) （98 - 107） , 2021
英語 ：Kakizaki H, Lee KS, Katou D, Yamamoto O, Sumarsono B, Uno S, Yamaguchi O. , Mirabegron add-on therapy to tamsulosin in men with overactive bladder: Post hoc analyses of efficacy from the MATCH study. , Advances in Therapy , 2020
英語 ： Fukudo M, Tamaki G, Azumi M, Kakizaki H, Tasaki Y. , Absorption of the orally active multikinase inhibitor axitinib as a therapeutic index to guide dose titration in metastatic renal cell carcinoma. , Investigational New Drugs , 2020
英語 ：Kakizaki H, Wada N, Watanabe M, Kita M, Hori J, Tamaki G. , Managing sphincter deficiency stress urinary incontinence in the neurogenic patients: Diagnosis and management strategies. , Current Bladder Dusfunction Reports , 2020
英語 ：Katoh T, Kakizaki H, Lee KS, Ishida K, Katou D, Yamamoto O, Jong JJ, Sumarsono B, Uno S, Yamaguchi O. , Cardiovascular safety of mirabegron add-on therapy to tamsulosin for the treatment of overactivebladder in men with lower urinary tract symptoms: A post-hoc analysis from the MATCH study. , Lower Urinary Tract Symptoms , 2020
英語 ：Wada N, Yoshimura N, Kurobe M, Saito T, Tyagi P, Kakizaki H. , The early, long-term inhibition of brain-derived neurotrophic factor improves voidings and storage dysfunctions in mice with spinal cord injury. , Neurourology and urodynamics, 39 (5) （1345 - 1354） , 2020
英語 ：Wada N, Kikuchi D, Tateoka J, Abe N, Watanabe M, Tamaki G, Kita M, Kakizaki H. , Persistence rate with tadalafil for treatment of male lower urinary tract symptoms. , Urol Int, 29 (4) （1 - 5） , 2020
英語 ：Sekido N, Igawa Y, Kakizaki H, Kitta T, Sengoku A, Takahashi S, Takahashi R, Tanaka K, Namima T, Honda M, Mitsui T, Yamanishi T,Watanabe T. , Clinical guidelines for the diagnosis and treatment of lower urinary tract dysfunction in patients with spinal cord injury , International Journal of Urology , 2020
英語 ：Yoshida M, Takeda M, Gotoh M, Yokoyama O, Kakizaki H, Takahashi S, Masumori N, Nagai S, Minemura K. , Efficacy of vibegron, a novel β3-adrenoceptor agonist, on severe urgency urinary incontinence related to overactive bladder: Post-hoc analysis of a randomized, placebo-controlled, double-blind comparative phase 3 study. , British Journal of Urology International , 2020
英語 ：Wada N, Kikuchi D, Tateoka J, Abe N, Banjo H, Tsuchida M, Hori J, Tamaki G, Kita M, Kakizaki H. , Long-term symptomatic outcome after transurethral resection of the prostate: A urodynamic-based assessment. , International Journal of Urology, 26 (11) （1071 - 1075） , 2019
英語 ：Yamaguchi O, Kakizaki H, Homma Y, Igawa Y, Takeda M, Nishizawa O, Gotoh M, Yoshida M, Yokoyama O, Seki N, Okitsu A, Hamada T, Kobayashi A and Kuroishi K. , Long-term safety and efficacy of antimuscarinic add-on therapy in patients with overactive bladder who had a suboptimal response to miranegron monotherapy: A multicenter, randomozed study in Japan (MILAI II study) , International Journal of Urology, 26 (3) （342 - 352） , 2019
英語 ：Yoshida M, Takeda M, Gotoh M, Yokoyama O, Kakizaki H, Takahashi S, Masumori N, Nagai S, Hashimoto K and Minemura K.: , Efficacy of novel β3-adrenoreceptor agonist vibegron on nocturia in patients with overactive bladder: A post-hoc analysis of a randomized, double-blind, placebo-controlled phase 3 study. , International Journal of Urology, 26 (3) （369 - 375） , 2019
英語 ：Rosier PFW, Kuo HC, De Gennaro M, Gammie A, Agro EF, Kakizaki H,Hashim H, Toozs-Hobson P. , International Consultation on Incontinence 2016; Executive summary: Urodynamic testing. , Neurourology and urodynamics, 38 (2) （545 - 552） , 2019
Copyright (C) 2012～ Asahikawa Medical University, All Rights Reserved.